Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation

Thrombosis and Haemostasis

Volumn 87, Issue 2, 2002, Pages 288-293

  Monteiro, Robson Q ^a   Zingali, Russolina B ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Bothrojaracin; Factor Va; Proexosite I; Prothrombin; Prothrombinase

Indexed keywords

ANION; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A 5A COMPLEX; BLOOD CLOTTING FACTOR 5A; BOTHROJARACIN; ENZYME PRECURSOR; EXOSITE 1; EXOSITE 2; HEPARIN COFACTOR; HIRUDIN; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROEXOSITE 1 LIGAND; PROTEINASE; PROTHROMBIN; SNAKE VENOM; THROMBIN; UNCLASSIFIED DRUG;

ARTICLE; COVALENT BOND; DRUG BINDING; DRUG EFFECT; DRUG INHIBITION; DRUG POTENCY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

EID: 0036166459     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612987     Document Type: Article

References (44)

1. Prothrombin
2. Membrane-dependent reactions in blood coagulation: Role of vitamin K-dependent enzyme complexes
3. The role of phospholipids and factor Va in the prothrombinase complex
4. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site
5. Activation-induced exposure of the thrombin anion-binding exosite
6. The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen
7. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity
8. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity
9. Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II
10. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: Analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases
11. Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments
12. Antithrombin properties of C-terminus of hirudin using synthetic unsulfated N-alpha-acetyl-hirudin45-65
13. A player of many parts: The spotlight falls on thrombin's structure
14. Thrombin specificity
15. Molecular mapping of the heparin-binding exosite of thrombin
16. Characterization of proexosite I on prothrombin
17. The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V
18. The second kringle domain of prothrombin promotes factor Va-mediated prothrombin activation by prothrombinase
19. Contribution of the prothrombin fragment 2 domain to the function of factor Va in the prothrombinase complex
20. Role of proexosite I in factor Va-dependent substrate interactions of prothrombin activation
21. Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom: Characterization and mechanism of thrombin inhibition
22. Bothrojaracin: A potent two-site-directed thrombin inhibitor
23. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin
24. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II
25. Characterization of bothrojaracin interaction with human prothrombin
26. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom
27. A novel one-step purification of human α-thrombin after direct activation of crude prothrombin enriched from plasma
28. Interaction of human alpha-thrombin and gamma-thrombin with antithrombin III, protein C and thrombomodulin
29. Human thrombins. Production, evaluation, and properties of alpha-thrombin
30. Platelet activation detected by turbidometric shape-change analysis: Differential influence of cytochalasin B and prostaglandin E1
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Molecular cloning and expression of bothrojaracin, a potent thrombin inhibitor from snake venom
33. A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): Isolation and characterization
34. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis
35. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2, prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid
36. Procoagulant expression in platelets and defects leading to clinical disorders
37. Changes in membrane phospholipid distribution during platelet activation
38. Platelet factor Xa receptor
39. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation
40. Platelet procoagulant activity and its measurement
41. Effect of hirudin carboxy-terminal peptide 54-65 on the interaction of thrombin with platelets
42. Prothrombinase complex assembly
43. Inhibition of thrombin-dependent feedback reactions is critical to the expression of the anticoagulant effects of heparin
44. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet-rich plasma